Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages

References

• Fehrenbach H. (2001). Alveolar epithelial type II cell: Defender of the alveolus revisited. Respir Res, 2:33–46.
   PubMed Web of Science ®Google Scholar
• Poelma DL, Zimmermann LJ, Scholten HH, Lachmann B, van Iwaarden JF. (2002). In vivo and in vitro uptake of surfactant lipids by alveolar type II cells and macrophages. Am J Physiol Lung Cell Mol Physiol, 283:648–54.
   Web of Science ®Google Scholar
• Ellner JJ, Goldberger MJ, Parenti DM. (1991). Mycobacterium avium infection and AIDS: A therapeutic dilemma in rapid evolution. J Infect Dis, 163:1326–35.
   PubMed Web of Science ®Google Scholar
• Doganay M. (2003). Listeriosis: Clinical presentation. FEMS Immunol Med Microbiol, 35:173–5.
   PubMed Web of Science ®Google Scholar
• Tarnvik A, Berglund L. (2003). Tularaemia. Eur Respir J, 21:361–73.
   PubMed Web of Science ®Google Scholar
• Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. (2003). Tuberculosis. Lancet, 362: 887–99.
   PubMed Web of Science ®Google Scholar
• Nara C, Tateda K, Matsumoto T, Ohara A, Miyazaki S, Standiford TJ. (2004). Legionella-induced acute lung injury in the setting of hyperoxia: Protective role of tumour necrosis factor-alpha. J Med Microbiol, 53:727–33.
   PubMed Web of Science ®Google Scholar
• Tsai MH, Huang YC, Chen CJ, Lin PY, Chang LY, Chiu CH, . (2005). Chlamydial pneumonia in children requiring hospitalization: Effect of mixed infection on clinical outcome. J Microbiol Immunol Infect, 38:117–22.
   PubMedGoogle Scholar
• Nadif R, Mintz M, Rivas-Fuentes S, Jedlicka A, Lavergne E, Rodero M, Kauffmann F, Combadiere C, Kleeberger SR. (2006). Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers’ pneumoconiosis. Cytokine, 33:171–8.
   PubMed Web of Science ®Google Scholar
• Brasch F, Birzele J, Ochs M, Guttentag SH, Schoch OD, Boehler A, . (2004). Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J, 24:426–35.
   PubMed Web of Science ®Google Scholar
• Alving CR, Steck EA, Chapman WL Jr, Waits VB, Hendricks LD, Swartz GM Jr, . (1980). Liposomes in leishmaniasis: Therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. Life Sci, 26:2231–8.
   PubMed Web of Science ®Google Scholar
• Magallanes M, Dijkstra J, Fierer J. (1993). Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis. Antimicrob Agents Chemother, 37:2293–7.
   PubMed Web of Science ®Google Scholar
• Deol P, Khuller GK, Joshi K. (1997). Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice. Antimicrob Agents Chemother, 41:1211–4.
   PubMed Web of Science ®Google Scholar
• Harashima H, Iida S, Urakami Y, Tsuchihashi M, Kiwada H. (1999). Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling. J Control Release, 61:93–106.
   PubMed Web of Science ®Google Scholar
• Tsuchihashi M, Harashima H, Kiwada H. (1999). Development of a pharmacokinetic/pharmacodynamic (PK/PD)-simulation system for doxorubicin in long circulating liposomes in mice using peritoneal P388. J Control Release, 61:9–19.
   PubMed Web of Science ®Google Scholar
• Chono S, Tauchi Y, Deguchi Y, Morimoto K. (2005). Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice. J. Drug Target, 13:267–76.
   PubMed Web of Science ®Google Scholar
• Chono S, Morimoto K. (2006). Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation. J Pharm Pharmacol, 58:1219–25.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. (2006). Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes. J Drug Target, 14:557–66.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. (2007). Pharmacokinetic and pharmacodynamic efficacy of intrapulmonary administration of ciprofloxacin for the treatment of respiratory infections. Drug Metab Pharmacokinet, 22:88–95.
   PubMed Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. (2008). Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects. Drug Dev Ind Pharm, 34:1090–6.
   PubMed Web of Science ®Google Scholar
• Lane KB, Egan B, Vick S, Abdolrasulnia R, Shepherd VL. (1998). Characterization of a rat alveolar macrophage cell line that expresses a functional mannose receptor. J Leukoc Biol, 64:345–50.
   PubMed Web of Science ®Google Scholar
• Kudo K, Sano H, Takahashi H, Kuronuma K, Yokota S, Fujii N, . (2004). Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor. J Immunol, 172:7592–602.
   PubMed Web of Science ®Google Scholar
• Chroneos ZC, Abdolrasulnia R, Whitsett JA, Rice WR, Shepherd VL. (1996). Purification of a cell-surface receptor for surfactant protein A. J Biol Chem, 271:16375–83.
   PubMed Web of Science ®Google Scholar
• Crowther JE, Schlesinger LS. (2006). Endocytic pathway for surfactant protein A in human macrophages: Binding, clathrin-mediated uptake, and trafficking through the endolysosomal pathway. Am J Physiol Lung Cell Mol Physiol, 290:334–42.
   Web of Science ®Google Scholar
• Gronlund J, Vitved L, Lausen M, Skjodt K, Holmskov U. (2000). Cloning of a novel scavenger receptor cysteine-rich type I transmembrane molecule (M160) expressed by human macrophages. J Immunol, 165:6406–15.
   PubMed Web of Science ®Google Scholar
• Palecanda A, Kobzik L. (2001). Receptors for unopsonized particles: The role of alveolar macrophage scavenger receptors. Curr Mol Med, 1:589–95.
   PubMedGoogle Scholar
• Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol, 13:238–52.
   PubMed Web of Science ®Google Scholar
• Derksen JT, Morselt HW, Scherphof GL (1987). Processing of different liposomal markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim Biophys Acta, 931:33–40.
   PubMed Web of Science ®Google Scholar
• Harashima H, Ochi Y, Kiwada H. (1994). Kinetic modelling of liposome degradation in serum: Effect of size and concentration of liposomes in vitro. Biopharm Drug Dispos, 15:217–25.
   PubMed Web of Science ®Google Scholar
• Antonini JM, Reasor MJ (1991). Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture. Biochem Pharmacol, 42:S151–6.
   PubMed Web of Science ®Google Scholar
• Kohno Y, Yoshida H, Suwa T, Suga T. (1990). Uptake of clarithromycin by rat lung cells. J Antimicrob Chemother, 26:503–13.
   PubMed Web of Science ®Google Scholar
• Rennard SI, Basset G, Lecossier D, O’Donnell KM, Pinkston P, Martin PG, . (1986). Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol, 60:532–8.
   PubMed Web of Science ®Google Scholar
• Barratt G, Tenu JP, Yapo A, Petit JF. (1986). Preparation and characterisation of liposomes containing mannosylated phospholipids capable of targetting drugs to macrophages. Biochim Biophys Acta, 862:153–64.
   PubMed Web of Science ®Google Scholar
• Kawakami S, Wong J, Sato A, Hattori Y, Yamashita F, Hashida M. (2000). Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim Biophys Acta, 1524:258–65.
   PubMed Web of Science ®Google Scholar
• Johansson J, Curstedt T, Robertson B. (1994). The proteins of the surfactant system. Eur Respir J, 7:372–91.
   PubMed Web of Science ®Google Scholar
• Benne CA, Benaissa-Trouw B, van Strijp JA, Kraaijeveld CA, van Iwaarden JF. (1997). Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis: Binding and neutralization. Eur J Immunol, 27:886–90.
   PubMed Web of Science ®Google Scholar
• Holmskov U, Mollenhauer J, Madsen J, Vitved L, Gronlund J, Tornoe I, . (1999). Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci USA, 96:10794–9.
   PubMed Web of Science ®Google Scholar
• Schagat TL, Wofford JA, Wright JR. (2001). Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J Immunol, 166:2727–33.
   PubMed Web of Science ®Google Scholar
• Beharka AA, Gaynor CD, Kang BK, Voelker DR, McCormack FX, Schlesinger LS. (2002). Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophage. J Immunol, 169:3565–73.
   PubMed Web of Science ®Google Scholar
• Harashima H, Houng TM, Ishida T, Manabe Y, Matsuo H, Kiwada H. (1996). Synergistic effect between size and cholesterol content in enhanced hepatic uptake clearance of liposomes through complement activation in rats. Pharmaceu Res, 13:1704–9.
   Web of Science ®Google Scholar
• Huong TM, Harashima H, Kiwada H. (1998). Complement dependent and independent liposome uptake by peritoneal macrophages: Cholesterol content dependency. Biol Pharm Bull, 21:969–73.
   PubMed Web of Science ®Google Scholar
• Huong TM, Harashima H, Kiwada H. (1999). In vivo studies on the role of complement in the clearance of liposomes in rats and guinea pigs. Biol Pharm Bull, 22:515–20.
   PubMed Web of Science ®Google Scholar
• Balagopal A, MacFarlane AS, Mohapatra N, Soni S, Gunn JS, Schlesinger LS. (2006). Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun, 74:5114–25.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Laursen SB, Willis AC, Sim RB. (1993). Localization of the receptor-binding site in the collectin family of proteins. Biochem J, 293:15–19.
   PubMed Web of Science ®Google Scholar
• Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, . (2006). Surfactant proteins SP-A and SP-D: Structure, function and receptors. Mol Immunol, 43:1293–315.
   PubMed Web of Science ®Google Scholar
• Hawgood S. (1991). Surfactant: Composition, structure, and metabolism. In: Crystal RG, West JB, . eds. The lung: Scientific foundations. New York: Raven Press, Ltd.
   Google Scholar
• Notter RH. (2000) Lung surfactants. Basic science and clinical applications. In: Lenfant C. ed. Lung biology in health and disease, vol. 149. New York: Marcel Dekker, Inc., 1–444.
   Google Scholar
• Alton G, Hasilik M, Niehues R, Panneerselvam K, Etchison JR, Fana F, . (1998). Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology, 8:285–95.
   PubMed Web of Science ®Google Scholar